Table 3. Univariate and multivariate analysis of risk factors for prognosis of gastric cancer patients in validation set.

Prognostic factors	β	Hazard ratio (95% CI)	P value	β	Hazard ratio (95% CI)	P value
Gender	0.128	1.137(0.916-1.410)	0.244
Age	0.181	1.198(1.000-1.436)	0.005	0.223	1.250(1.000-1.562)	0.050
Tumor location	0.008	1.008(0.919-1.105)	0.869
Tumor size	1.057	2.879(2.400-3.453)	<0.001	0.283	1.327(1.045-1.684)	0.020
Pathological type	0.415	1.515(1.340-1.711)	<0.001
Tumor depth	0.799	2.224(1.983-2.494)	<0.001	0.453	1.573(1.317-1.880)	<0.001
Lymph node metastasis	0.750	2.117(1.944-2.305)	<0.001	0.550	1.734(1.533-1.962)	<0.001
Tumor stage	1.329	3.776(3.191-4.468)	<0.001
Lymphatic-vascular invasion	1.174	3.234(2.475-4.226)	<0.001
Neural invasion	1.389	4.012(2.699-5.964)	<0.001	0.453	1.574(1.031-2.403)	0.036
NWR	0.329	1.389(1.147-1.682)	0.001
LWR	−0.426	0.653(0.545-0.783)	<0.001	−0.389	0.678(0.540-0.851)	0.001
MWR	0.247	1.281(1.068-1.536)	0.008	0.334	1.397(1.112-1.755)	0.004
NLR	0.396	1.486(1.232-1.791)	<0.001
MLR	0.410	1.506(1.226-1.851)	<0.001
PLR	0.435	1.545(1.289-1.852)	<0.001